Results 291 to 300 of about 69,107 (331)

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Highlights: Introduction Pharmacology Treatment Advantages/Disadvantages Therapeutic Considerations Monographs ...
Kimberly C. McKeirnan, Joshua J. Neumiller   +1 more
  +4 more sources

Highlight: Dipeptidyl peptidase 4 and related proteins

Biological Chemistry, 2011
No abstract ...
Torsten, Hoffmann, Hans-Ulrich, Demuth
openaire   +2 more sources

Dipeptidyl peptidase-4 inhibitors

2016
Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.
openaire   +1 more source

Renal outcomes with dipeptidyl peptidase-4 inhibitors

Diabetes & Metabolism, 2018
Dipeptidyl peptidase-4 inhibitors (DPP-4is) are increasingly being used in the management of type 2 diabetes (T2D). The present review summarizes the current knowledge of the effects of DPP-4is on renal outcomes by analyzing the experimental preclinical data, the effects of DPP-4is on urinary albumin-creatinine ratios (UACRs) and estimated glomerular ...
Scheen, André, DELANAYE, Pierre
openaire   +3 more sources

Pharmacology of Dipeptidyl Peptidase-4 Inhibitors

Drugs, 2011
The dipeptidyl peptidase (DPP)-4 inhibitors, which enhance glucose-dependent insulin secretion from pancreatic β cells by preventing DPP-4-mediated degradation of endogenously released incretin hormones, represent a new therapeutic approach to the management of type 2 diabetes mellitus. The 'first-in-class' DPP-4 inhibitor, sitagliptin, was approved in
R. Baetta, A. Corsini
openaire   +2 more sources

Dipeptidyl peptidase-4-remmers (DPP-4-remmers)

Huisarts en wetenschap, 2013
die een behandeling met DPP-4-remmers kregen. De Cochrane-review liet geen significante verschillen zien tussen sitagliptine en vildagliptine vergeleken met andere orale antidiabetica.2 Een gerandomiseerd onderzoek rapporteerde significant minder hypoglykemieen (5%) met sitagliptine dan met glipizide (32%) dat was toegevoegd aan metformine.4 ...
openaire   +1 more source

Dipeptidyl-peptidase-4-inhibitors

Reactions Weekly, 2023
openaire   +1 more source

Dipeptidyl Peptidase-4

RCSB Protein Data Bank, 2016
openaire   +2 more sources

Dipeptidyl Peptidase-4 – A Comprehensive Review

Current Enzyme Inhibition
Abstract: Type 2 diabetes mellitus is a growing global public health issue, with its prevalence projected to increase in the coming decades. It is one of the most prevalent and growing global health concerns, affecting millions of individuals worldwide.
V. Parthasarathi, Hemalatha K.
openaire   +1 more source

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan, Viswanathan Mohan, Gaurav Beswal   +2 more
openaire   +1 more source